Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Common side effects (usually temporary): Nausea (most frequent, especially after injections) Constipation or loose stools Fatigue and low energy in the first few weeks Reduced appetite (this is also the intended effect) Injection site reactions Less common but serious: Pancreatitis (seek care immediately if you have severe abdominal pain) Gallbladder problems Changes in heart rate Rare thyroid concerns (see contraindications above) Staying well hydrated is important throughout treatment
However, this is based on a single case report, not large-scale comparative trials
As low as $195 As low as $100 As low as $100 As low as $195 As low as $180 As low as $185 As low as $180 As low as $95
Lab testing, if required, is not included in the monthly medication costs and you typically pay $75$100 out of pocket
If you have type 2 diabetes, you may see some reduction in your blood sugar levels
These included CT-996, a once-daily oral small-molecule oral GLP-1 receptor agonist, in Phase I, for treating obesity in patients with and without Type 2 diabetes, as well as two injectable clinical drug candidates: CT-388, a once-weekly subcutaneous injectable in Phase II, for treating obesity in patients with and without Type 2 diabetes, and CT-868, a once-daily subcutaneous injectable, in Phase II, for treating Type 1 diabetes patients with overweight or obesity
US$ 24.21
US$ 21.23
US$ 21.89
US$ 21.51
US$ 24.80
